National Cancer Institute, National Institutes of Health, Rockville, MD, USA.
J Clin Oncol. 2011 Apr 20;29(12):1592-8. doi: 10.1200/JCO.2010.31.5200. Epub 2011 Mar 21.
To further clarify the relationship between total cholesterol and cancer, which remains unclear.
We prospectively examined the association between total cholesterol and site-specific and all-cancer incidence among 1,189,719 Korean adults enrolled in the National Health Insurance Corporation who underwent a standardized biennial medical examination in 1992 to 1995 and were observed for 14 years until cancer diagnosis or death.
Over follow-up, 53,944 men and 24,475 women were diagnosed with a primary cancer. Compared with levels less than 160 mg/dL, high total cholesterol (≥ 240 mg/dL) was positively associated with prostate cancer (hazard ratio [HR], 1.24; 95% CI, 1.07 to 1.44; P trend = .001) and colon cancer (HR, 1.12; 95% CI, 1.00 to 1.25; P trend = .05) in men and breast cancer in women (HR, 1.17; 95% CI, 1.03 to 1.33; P trend = .03). Higher total cholesterol was associated with a lower incidence of liver cancer (men: HR, 0.42; 95% CI, 0.38 to 0.45; P trend < .001; women: HR, 0.32; 95% CI, 0.27 to 0.39; P trend < .001), stomach cancer (men: HR, 0.87; 95% CI, 0.82 to 0.93; P trend ≤ .001; women: HR, 0.86; 95% CI, 0.77 to 0.97; P trend = .06), and, in men, lung cancer (HR, 0.89; 95% CI, 0.82 to 0.96; P trend < .001). Results for liver cancer were slightly attenuated after additional adjustment for liver enzyme levels and hepatitis B surface antigen status (men: HR, 0.60; P trend < .001; women: HR, 0.46; P trend = .003) and exclusion of the first 10 years of follow-up (men: HR, 0.59; P trend < .001; women: HR, 0.44; P trend < .001). Total cholesterol was inversely associated with all-cancer incidence in both men (HR, 0.84; 95% CI, 0.81 to 0.86; P trend < .001) and women (HR, 0.91; 95% CI, 0.87 to 0.95; P trend < .001), but these associations were attenuated after excluding incident liver cancers (men: HR, 0.95; P trend < .001; women: HR, 0.98; P trend = .32).
In this large prospective study, we found that total cholesterol was associated with the risk of several different cancers, although these relationships differed markedly by cancer site.
进一步阐明总胆固醇与癌症之间的关系,目前这方面的关系仍不清楚。
我们前瞻性地研究了在韩国 1189719 名成年人中,总胆固醇与特定部位和所有癌症发病率之间的关系,这些成年人参加了国民健康保险公社的标准化两年一次的体检,于 1992 年至 1995 年进行体检,并在随访 14 年期间观察癌症诊断或死亡。
在随访期间,53944 名男性和 24475 名女性被诊断出患有原发性癌症。与低于 160mg/dL 的水平相比,高总胆固醇(≥240mg/dL)与前列腺癌(危险比[HR],1.24;95%置信区间,1.07 至 1.44;P 趋势=0.001)和结肠癌(HR,1.12;95%置信区间,1.00 至 1.25;P 趋势=0.05)在男性和乳腺癌在女性中呈正相关(HR,1.17;95%置信区间,1.03 至 1.33;P 趋势=0.03)。较高的总胆固醇与肝癌(男性:HR,0.42;95%置信区间,0.38 至 0.45;P 趋势<0.001;女性:HR,0.32;95%置信区间,0.27 至 0.39;P 趋势<0.001)、胃癌(男性:HR,0.87;95%置信区间,0.82 至 0.93;P 趋势≤0.001;女性:HR,0.86;95%置信区间,0.77 至 0.97;P 趋势=0.06)的发病率较低相关,在男性中还与肺癌(HR,0.89;95%置信区间,0.82 至 0.96;P 趋势<0.001)的发病率较低相关。在进一步调整肝酶水平和乙型肝炎表面抗原状态(男性:HR,0.60;P 趋势<0.001;女性:HR,0.46;P 趋势=0.003)以及排除随访的前 10 年后,肝癌的结果略有减弱(男性:HR,0.59;P 趋势<0.001;女性:HR,0.44;P 趋势<0.001)。总胆固醇与男性(HR,0.84;95%置信区间,0.81 至 0.86;P 趋势<0.001)和女性(HR,0.91;95%置信区间,0.87 至 0.95;P 趋势<0.001)的所有癌症发病率呈负相关,但这些关联在排除肝癌后减弱(男性:HR,0.95;P 趋势<0.001;女性:HR,0.98;P 趋势=0.32)。
在这项大型前瞻性研究中,我们发现总胆固醇与几种不同癌症的风险相关,尽管这些关系在癌症部位上有明显差异。